Terms and Conditions

OncShare Ltd (“OncShare”) is a fully independent provider of micro-learning for oncologists around the world, and is based in England, UK.  Content is developed by oncology experts (“Experts”) supported by project and writing support overseen by OncShare.

All OncShare content is:

  • developed and intended for healthcare professionals, for information and education purposes
  • developed for a global audience, recognising that guidance, funding and availability of healthcare solutions differs by country and region ie. may not be suitable for every location
  • 100% independently funded (either by OncShare itself and/or via fully independent medical educational grants from pharmaceutical companies)
  • developed with core principles of accuracy, fairness, balance and impartiality
  • not to be used or interpreted as a substitute for professional advice or guidelines

OncShare content viewers and users (“the user” or “you”) accept that:

  • Opinions expressed in content reflect those of the experts, and are not the views of the institutions at which they work or OncShare Ltd
  • Content is accurate at the time of issue to the best knowledge of OncShare Ltd, but some aspects may develop and change over time
  • Content is there for information and education but must never be regarded as professional medical advice
  • Content has not been directed or influenced at all by sponsoring pharmaceutical companies – it is fully independent
  • Experts have been compensated for their time and expertise in preparing content

OncShare independent grant providers (“Funding Companies”) accept that:

  • Content is developed by OncShare and the Experts with the aim of educating and informing practising oncologists
  • OncShare content is fully independent of the agenda or business activities of any Funding Companies
  • Grants are provided to support provision of quality education and information, with nothing sought in return
  • Funding Companies may not be involved with agenda setting, expert choice nor any other aspect of content development or approval
  • Funding Companies accept all content produced by OncShare with no recourse before, during or after publication

HCP payments